Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Behind every facility expansion, technology investment, and quality milestone in the CDMO sector is a leadership team making deliberate choices about where to focus, how to grow, and when to take calculated risks.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
A video roundup of the week’s top industry news stories.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
Contract Pharma Stream offers a centralized destination where users can watch expert-led sessions anytime, anywhere
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
24 Corporate Circle, Albany, NY, 12203, US
Curia is a CDMO with over 30 years of experience, 20+ global sites and 3,000 employees. Our small molecules, generic APIs and biologics offerings span discovery to commercialization, with integrated regulatory and analytical capabilities. Our state-of-the-art facilities enable efficient drug manufacturing, accelerating life-changing therapeutics.
Unleashing Excellence in Quality, Supply Chain, HPAPIs & Orphan Drugs.
Released By Curia
Effective strategies to secure and de-risk pharmaceutical supply chains and how Curia assures the continual production of urgently needed drugs.
The current trend of increased potency of drug substances is driving the need for better cleaning methods to reduce cross contamination.
Salter-Cid’s expertise in immunology and immuno-oncology will be called upon as Harbour expands a pipeline of differentiated antibody therapeutics.
By: Patrick Lavery
Strengthens its ability to provide a seamless path from DNA to IND submission for its customers.
By: Charlie Sternberg
The expansion adds Denmark, Finland, Norway, and Sweden to 13 markets already covered in the partnership in Southeast Europe.
Rapid growth over the last 12 months has seen the business more than double in size.
The acquisition adds gamgertamig to Gilead’s inflammation portfolio and will be the foundation of Lakefront’s clinical development pipeline.
Appoints Dr. Alison D. Schecter as Chief Medical Officer and Alex Schwartz as Chief Financial Officer.
Expanded testing capability helps reduce delays in advanced therapy manufacturing.
Adds next-generation ADC assets and a platform designed to maximize patient benefit through more selective delivery of diverse payloads to tumors.
The completed transfer supports U.S. final drug product manufacturing for IBTROZI.
Rebar will focus on translating CPTx’s proprietary ssDNA vector technology into in-vivo CAR-T therapeutic leads.
EvoLVcell is designed to reduce batch‑to‑batch variability, improve vector quality, and provide a more predictable long‑term production strategy for LVVs.
The new line of high-clarity PETG bottles is designed to support the demanding requirements of pharmaceutical and biopharmaceutical manufacturing environments.
The appointments impact Ardena’s financial strategy as well as business development and marketing.
Sigfried adds API and specialty-chemistry assets; SK Capital retains finished-dose platform Halo.
Deal adds an AI-enabled, end-to-end PV technology platform designed to improve accuracy, cycle times, and compliance.
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !
